Q-linea AB (publ) (QLINEA.ST)
SEK 0.97
(-1.62%)
SEK 0.97
(-1.62%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -230.58 Million SEK | 11.84% |
| 2022 | -262.24 Million SEK | -12.29% |
| 2021 | -233.55 Million SEK | -5.42% |
| 2020 | -221.54 Million SEK | -23.69% |
| 2019 | -179.11 Million SEK | -40.63% |
| 2018 | -127.36 Million SEK | -87.66% |
| 2017 | -67.86 Million SEK | -12.95% |
| 2016 | -60.08 Million SEK | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -57.16 Million SEK | -3.39% |
| 2024 Q2 | -65.35 Million SEK | -14.32% |
| 2023 Q2 | -64.6 Million SEK | -3.79% |
| 2023 FY | -231.2 Million SEK | 11.84% |
| 2023 Q1 | -62.24 Million SEK | -6.56% |
| 2023 Q4 | -55.29 Million SEK | -14.59% |
| 2023 Q3 | -48.25 Million SEK | 25.31% |
| 2022 FY | -262.24 Million SEK | -12.29% |
| 2022 Q4 | -58.41 Million SEK | 0.87% |
| 2022 Q3 | -58.92 Million SEK | 19.37% |
| 2022 Q2 | -73.08 Million SEK | -1.74% |
| 2022 Q1 | -71.83 Million SEK | -39.16% |
| 2021 Q2 | -68.15 Million SEK | -6.89% |
| 2021 FY | -233.55 Million SEK | -5.42% |
| 2021 Q3 | -50.01 Million SEK | 26.61% |
| 2021 Q4 | -51.62 Million SEK | -3.2% |
| 2021 Q1 | -63.75 Million SEK | -11.73% |
| 2020 FY | -221.54 Million SEK | -23.69% |
| 2020 Q4 | -57.06 Million SEK | -14.2% |
| 2020 Q2 | -58.6 Million SEK | -4.84% |
| 2020 Q3 | -49.97 Million SEK | 14.74% |
| 2020 Q1 | -55.9 Million SEK | 9.92% |
| 2019 Q2 | -44.49 Million SEK | -21.16% |
| 2019 FY | -179.11 Million SEK | -40.63% |
| 2019 Q4 | -62.05 Million SEK | -73.17% |
| 2019 Q3 | -35.83 Million SEK | 19.46% |
| 2019 Q1 | -36.72 Million SEK | 5.81% |
| 2018 Q2 | -35.65 Million SEK | -48.99% |
| 2018 Q3 | -28.79 Million SEK | 19.24% |
| 2018 Q1 | -23.93 Million SEK | -9.56% |
| 2018 Q4 | -38.98 Million SEK | -35.41% |
| 2018 FY | -127.36 Million SEK | -87.66% |
| 2017 FY | -67.86 Million SEK | -12.95% |
| 2017 Q2 | -16.29 Million SEK | -8.55% |
| 2017 Q3 | -16 Million SEK | 1.78% |
| 2017 Q4 | -21.84 Million SEK | -36.46% |
| 2017 Q1 | -15.01 Million SEK | 0.0% |
| 2016 FY | -60.08 Million SEK | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AddLife AB (publ) | 585 Million SEK | 139.417% |
| Biotage AB (publ) | 376 Million SEK | 161.326% |
| Bonesupport Holding AB (publ) | 13.93 Million SEK | 1755.327% |
| Doxa AB (publ) | 269.4 Million SEK | 185.593% |
| Elekta AB (publ) | 2.03 Billion SEK | 111.309% |
| iZafe Group AB (publ) | -35.63 Million SEK | -547.08% |
| Ortivus AB (publ) | -17.61 Million SEK | -1209.261% |
| Ortivus AB (publ) | -17.61 Million SEK | -1209.261% |
| S2Medical AB (publ) | -15.26 Million SEK | -1410.672% |
| Synsam AB (publ) | 696 Million SEK | 133.13% |